Two Types of K⁺ Channel Subunit, Erg1 and KCNQ2/3, Contribute to the M-Like Current in a Mammalian Neuronal Cell by Selyanko, AA et al.
Two Types of K
1 Channel Subunit, Erg1 and KCNQ2/3, Contribute
to the M-Like Current in a Mammalian Neuronal Cell
A. A. Selyanko,1 J. K. Hadley,1 I. C. Wood,2 F. C. Abogadie,2 P. Delmas,2 N. J. Buckley,2 B. London,3 and
D. A. Brown1
1Department of Pharmacology, 2Wellcome Laboratory for Molecular Pharmacology, University College London,
London, WC1E 6BT, United Kingdom, and 3Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh,
Pennsylvania 15213
The potassium M current was originally identiﬁed in sympa-
thetic ganglion cells, and analogous currents have been re-
ported in some central neurons and also in some neural cell
lines. It has recently been suggested that the M channel in
sympathetic neurons comprises a heteromultimer of KCNQ2
and KCNQ3 (Wang et al., 1998) but it is unclear whether all
other M-like currents are generated by these channels. Here we
report that the M-like current previously described in NG108–15
mouse neuroblastoma x rat glioma cells has two components,
“fast” and “slow”, that may be differentiated kinetically and
pharmacologically. We provide evidence from PCR analysis and
expression studies to indicate that these two components are
mediated by two distinct molecular species of K
1 channel: the
fast component resembles that in sympathetic ganglia and is
probably carried by KCNQ2/3 channels, whereas the slow
component appears to be carried by merg1a channels. Thus,
the channels generating M-like currents in different cells may be
heterogeneous in molecular composition.
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The M current (IK(M)) is a low-threshold, slowly activating po-
tassium current that exerts an inhibitory control over neuronal
excitability; this inhibition can be relieved by neurotransmitters
acting on G-protein-coupled receptors, leading to enhanced ex-
citability and reduced spike-frequency adaptation (Brown, 1988;
Marrion, 1997). The current was originally described in sympa-
thetic neurons (Brown and Adams, 1980; Constanti and Brown,
1981), and analogous currents have subsequently been identiﬁed
in a variety of other neuronal and non-neuronal cells. Because the
precise kinetic and pharmacological properties of the current vary
somewhat in different cell types, the name “M-like” is often
applied to this current family.
Recently, evidence has been provided to indicate that the
channels that generate the M current in rat sympathetic neurons
are composed of a heteromeric assembly of KCNQ2 and KCNQ3
subunits (Wang et al., 1998; see also Yang et al., 1998). These are
two homologs of the KCNQ1 (KvLQT1) channel, mutations of
which are responsible for one form of the cardiac “long QT”
syndrome (Yang et al., 1997). In contrast, KCNQ2 and KCNQ3
are restricted to the nervous system, and mutations in these
channels are associated with a form of infant epilepsy termed
“benign familial neonatal convulsions” (Biervert et al., 1998;
Charlier et al., 1998; Schroeder et al., 1998; Singh et al., 1998).
However, it is not yet known whether all M-like channels are
composed of these two subunits (or homologs thereof), or
whether members of other K
1 channel gene families might con-
tribute to the generation of M-like currents.
In the present experiments, we have attempted to identify the
molecular species of K
1 channels that generate the M-like cur-
rent (IK(M,ng)) in NG108–15 mouse neuroblastoma x rat glioma
cells. These currents have been particularly well characterized
(Higashida and Brown, 1986; Brown and Higashida, 1988a,b;
Fukuda et al., 1988; Schafer et al., 1991; Robbins et al., 1992,
1993; Selyanko et al., 1995). Like the channels in sympathetic
neurons, they are inhibited by transmitters acting on G-protein-
linked receptors coupled to phospholipase C (e.g., bradykinin and
M1 and M3 muscarinic receptors) (Higashida and Brown, 1986;
Fukuda et al., 1988), with similar consequences for cell ﬁring
(Robbins et al., 1993). On the other hand, the kinetics of IK(M,ng)
appear more complex than those of the ganglionic M current
(Robbins et al., 1992), and the two currents differ in their sensi-
tivities to 9-aminotetrahydroacridine (cf. Marsh et al., 1990; Rob-
bins et al., 1992) and linopirdine (cf. Aiken et al., 1995; Lamas et
al., 1997; Noda et al., 1998). It has previously been suggested that
Shaker-type Kv1.2 channels, cloned from NG108–15 cells
(Yokoyama et al., 1989), may contribute to IK(M,ng) (Morielli and
Peralta, 1995). However, the insensitivity of IK(M,ng) to dendro-
toxin (Selyanko et al., 1995) makes this unlikely. Instead, we
provide evidence to indicate that two different types of K
1
channel contribute to the M-like current in NG108–15 cells: the
mouse ether-a-go-go-related gene (merg1a), also expressed in the
brain (London et al., 1997), and KCNQ2/KCNQ3, the proposed
substrate for the ganglionic current (Wang et al., 1998).
MATERIALS AND METHODS
Cell cultures. NG108–15 mouse neuroblastoma x rat glioma hybrid cells,
subclone BM8 (PM1), transfected to express pig brain M1 muscarinic
receptor (Fukuda et al., 1988), were cultured and differentiated as de-
scribed previously (Robbins et al., 1992). Chinese hamster ovary (CHO)
cells stably transfected with cDNA encoding human M1 muscarinic
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The Journal of Neuroscience, September 15, 1999, 19(18):7742–7756Figure 1. Pharmacological separation of two components of the M-like (IK(M,ng)) current in NG108–15 mouse neuroblastoma x rat glioma cells. M-like
currents recorded in two cells (A, B) as deactivating tail currents produced by voltage steps from 220 mV (holding potential) to 250 mV. In each cell,
the control current had two different components, fast and slow, which could be blocked by WAY 123,398 and linopirdine, respectively. Insets on the right
show the difference (blocker-sensitive) currents. The current in A consisted predominantly of the slow component (blocked by WAY 123,398), whereas
that in B was predominantly fast and blocked by linopirdine.






Total (control) 117 6 5 msec 658 6 29 msec 3434 6 159 msec
33.1 6 2.1% (86/101) 25.7 6 1.7% (82/101) 41.2 6 2.2% (86/101)
333 6 126 msec 2356 6 247 msec
42.5 6 5.1% (14/101) 57.6 6 5.1% (15/101)
Fast (WAY-insensitive) 104 6 7 msec (37)
Slow (WAY-sensitive) 456 6 29 msec 2718 6 156 msec
41.7 6 3.5% (34/36) 58.3 6 3.5% (36/36)
IK(M) 93 6 5.6 msec (n 5 15)
Imerg1a 183 6 10.6 msec 1012 6 85 msec
64.6 6 2.4% (22/23) 35.4 6 2.4% (23/23)
Imerg1b 37.1 6 19.4 msec 112 6 42.5 msec
70.8 6 15.8% (3/3) 29.2 6 15.8% (3/3)
IK(M,ng), IK(M), Imerg1a, and Imerg1b were recorded from NG108-15, mouse sympathetic, and CHO cells, respectively.
Deactivation was recorded in response to a voltage step to 250 mV from a holding potential of 220 mV (IK(M,ng) and IK(M))
o r0m V( Imerg1a and Imerg1b). Means 6 SEM of t and contributions were obtained from deactivation relaxations recorded
at 250 mV. Number of cells in parentheses; see Results.
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(1993). Superior cervical ganglion neurons were prepared as described
previously (Owen et al., 1990) from 6-week-old C57 mice and 14-d-old
Sprague Dawley rats, and used after 1–2 d in culture. Recordings from all
three types of cell were made at room temperature (20–22°C), under
identical experimental conditions (solutions, pipettes, etc.).
Culture and transfection of CHO hm1 cells. CHO hm1 cells are
CHO-K1 cells, previously transfected with the human M1 receptor (Mul-
laney et al., 1993). Cells were grown in 50 ml ﬂasks at 37°C and 5% CO2.
The culture medium was a-MEM supplemented with 10% fetal calf
serum, 1% L-glutamine, and 1% penicillin/streptomycin. Cells were split
twice weekly when conﬂuent, plated in 35 mm dishes, and transfected
1–2 d after plating using “LipofectAmine Plus” (Life Technologies,
Gaithersburg, MD) according to the manufacturer’s recommendations.
Plasmids containing merg1a and CD8 cDNAs, both driven by cytomeg-
alovirus promoter, were cotransfected in a ratio of 10:1. Cells for patch
clamping were identiﬁed by adding CD8-binding Dynabeads (Dynal,
Great Neck, NY) the day after transfection. For immunocytochemistry,
a plasmid containing cDNA for jellyﬁsh green ﬂuorescent protein (GFP)
was used as a marker for transfection.
Reverse transcription PCR. RNA was extracted from cell lines and
superior cervical ganglia (SCG) using RNAzol B (Biogenesis Ltd.) and
reverse-transcribed using oligo-dT and mouse murine leukemia virus
reverse transcriptase (Promega, Madison, WI). The oligonucleotides
used to amplify the erg gene family were: erg-s 59 CCCYTTCAAGGC-
MGTGTGGG and erg-a 59 CTGGTHAGRCTGCTGAAGGT. Primers
were designed such that the ampliﬁed product spanned at least one intron
to ensure ampliﬁcation products were not derived from contaminating
genomic DNA. The primers used for KCNQ PCR were KCNQs 59ACCT-
GGARGCTBCTGGCTC and KCNQa 59CCKCTYTTCTCAAAGT-
GCTTCTG. These primers were designed to amplify both KCNQ2 and
KCNQ3 sequences. Cycling conditions were 95°C for 5 min and then 30
cycles of 95°C for 30 sec; 60°C for 1 min and 72°C for 1 min followed by
a ﬁnal step of 72°C for 10 min. Aliquots of the reaction mixture were
visualized on a 2% (w/v) Metaphor agarose (FMC BioProducts, Rock-
land, ME). PCR products were cloned using the pGEM-T vector (Pro-
mega) and recombinant plasmids sequenced using Taq polymerase, ﬂuo-
resceinated dye terminators and an Applied Biosystems 377 automated
DNA sequencer.
Immunocytochemistry. This was performed using antibodies raised
against synthetic peptides corresponding to the last 14 amino acids of the
C-terminal fragment of merg1 (merg1-CT) and the ﬁrst 17 amino acids
of merg1b (merg1-NT), respectively. NG108–15 cells were seeded onto
polyornithine-coated glass coverslips to allow immunocytochemistry.
NG108–15 cells were washed in TBS (5.5 mM Tris, pH 7.4, and 137 mM
NaCl) and ﬁxed in acetone for 20 min at room temperature. The ﬁxed
cells were then treated with normal swine serum (1:10) in TBS for 30
min. Once excess serum was removed, the merg1-CT primary antibody
was applied at 1:1000 dilution for 1 hr at room temperature. Different
concentrations of the primary antibody were tested to optimize immu-
nochemical labeling and minimize nonspeciﬁc staining of the tissue
background. Bound antibodies were then detected using alkaline
phosphatase-conjugated secondary antibodies (1:500; Dako, Carpinteria,
CA), largely as described in Abogadie et al. (1997). Transfected mam-
malian CHO cells were brieﬂy washed with PBS and ﬁxed for 20–30 min
in PBS containing 4% paraformaldehyde. Fixed cells were then rinsed
Figure 2. Kinetic analysis of the M-like current in a NG108–15 mouse
neuroblastoma x rat glioma cell. Total IK(M,ng) was activated by holding at
220 mV and then deactivated by a 6 sec step (top record)t o250 mV
before (A) and after (B) addition of the erg-channel blocker WAY 123,398
(10 mM). In control (A) the deactivation tail was ﬁtted (smooth line,
superimposed) by the sum of fast (t 5 76 msec, 254 pA) and two slow (t 5
340 msec, 37 pA and 2124 msec, 70 pA) exponential curves. WAY 123,398
abolished both slow components without affecting the fast component (B,
t 5 76 msec). C, Slow component obtained by subtracting the record
shown in B from that shown in A was ﬁtted (smooth line, superimposed)
by the sum of two kinetic components (t 5 315 and 1972 msec). All
records were obtained from the same cell. Dashed lines denote zero
current levels.
Figure 3. cDNA from mouse SCG, rat SCG, and chemically differenti-
ated NG108–15 cells, was ampliﬁed using primers to the erg family of
potassium channel genes or primers recognizing KCNQ2 and KCNQ3
potassium channel genes. Ampliﬁed products were obtained from all cell
types but not from a negative control containing no template, indicating
that members of these families are expressed by these cells. Sequence
analysis revealed that the ampliﬁed product obtained from NG108–15
cDNA with primers to the erg genes was predominantly, if not exclusively,
merg1. Analysis of the ampliﬁed product obtained using the KCNQ
primers in both rat SCG and NG108–15 has shown these cells express
both KCNQ2 and KCNQ3. M-1 kb ladder DNA size standards.
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Triton X-100 for 5 min. Incubation with the anti-merg1 antibody and
labeling were carried out as described for the NG108–15 cells.
Perforated-patch whole-cell recording. Cells were bath-perfused with
the solution of the following composition (in mM): 144 NaCl, 2.5 KCl, 2
CaCl2, 0.5 MgCl2, 5 HEPES, and 10 glucose, pH 7.4, with Tris base.
Pipettes were ﬁlled with the “internal” solution containing 90 mM K
acetate, 20 mM KCl, 40 HEPES, 3 MgCl2,3m M EGTA, and 1 mM
CaCl2. The pH was adjusted to 7.4 with NaOH. Amphotericin B was
used to perforate the patch (Rae et al., 1991). The series resistance was
not compensated because the error introduced was reasonably small.
Thus, with the electrodes used (2–3 MV), the series resistance was 6–8
MV, and most of the currents were ,0.5 nA, so the voltage error would
be ,5 mV. As conﬁrmation that the voltage error was small, no corre-
lation was found between deactivation time constants and initial current
amplitude.
Data acquisition and analysis. Data were acquired and analyzed using
pClamp software (version 6.0.3). Currents were recorded using an Axo-
patch 200A (or 200) patch-clamp ampliﬁer, ﬁltered at 1 kHz, and digi-
tized at 1–4 kHz. In current-clamp experiments, currents were injected,
and membrane potential was recorded using an Axoclamp-2 ampliﬁer.
Activation curves were ﬁtted by the Boltzmann equation: I/I(50) 5 1/(1
1 exp(V1/2 2 V)/k), where I is current at the test potential (estimated
from the amplitudes of exponentials backﬁtted to the beginning of the
test step), I(50) is current at 150 mV, V1/2 is the membrane potential, V,
at which I is equal to 1⁄2 I(50). Inhibition of the current was measured
from the change in the amplitude of the deactivation tail recorded at 250
mV. Each tail was ﬁtted by one or more exponentials, and the tail
amplitude was taken as the sum of the amplitudes of all components
contributing to it after backﬁtting them to the beginning of the hyper-
polarizing pulse. In cells that had the erg-type component, backﬁtting was
necessary to exclude not only the (relatively fast) capacity transient, but
also the brief rising phase of the tail caused by the deinactivation of
erg-type channels. To include the fast component (when present) in the
ﬁt, we had to position the ﬁtting cursor earlier in the trace than was
appropriate for the pure erg current. This tends to skew the t values
obtained for the erg components to larger values. This may explain the
difference in slow t values between the total and WAY 123,398-sensitive




nH), where Ymax is the maximum inhibition, x is the
blocker concentration, nH is the slope (Hill coefﬁcient), and IC50 is the
concentration corresponding to the half-maximal inhibition. Individual
currents were measured and ﬁtted using the Clampﬁt software, whereas
the program “Origin” (version 5.0, Microcal Software) was used for
ﬁtting activation and inhibition curves and for creating the ﬁgures.
Drugs and chemicals. Linopirdine (DuP 996) was obtained from Re-
search Biochemicals (Natick, MA). WAY 123,398 and azimilide were
kindly provided by Wyeth-Ayerst Research (Princeton, NJ) and Dr. A.
Busch (DG Cardiovascular, Frankfurt, Germany), respectively. All other
drugs and chemicals were obtained from Sigma or BDH Chemicals
(Poole, UK).
RESULTS
Fast and slow M-like (IK(M,ng)) currents in NG108–15
mouse neuroblastoma x rat glioma cells
We recorded M-like currents (IK(M,ng)) from 101 chemically dif-
ferentiated NG108–15 cells using perforated-patch electrodes.
Cells were carefully selected for their “neuron-like” appearance,
i.e., large size and well-developed neuropil (Robbins et al., 1992).
When studied with the conventional M-current voltage protocol,
that is, by stepped hyperpolarization after predepolarization to
approximately 220 mV (see Materials and Methods), currents
showed characteristic M-like deactivation tails. However, the
time course of these tail currents varied considerably from one
cell to another. Figure 1 illustrates two extreme examples of this
variation. Thus, in Figure 1A, deactivation during a 6 sec hyper-
polarizing step was very slow, with an apparent “time-constant”
of ;2 sec, whereas in Figure 1B, deactivation was complete
within 2 sec.
Because a number of tumor cells (including neuroblastoma
cells) have been reported to express HERG-like currents with
Figure 4. Immunocytochemical detection of merg1 protein in differen-
tiated NG108 cells. Immunostaining for the C terminus of merg1 in
chemically differentiated (A) and undifferentiated (B) NG108 cells, and
in dissociated mouse SCG cells (C). Note that in A, a large NG108–15 cell
(arrow) showed labeling of strong intensity, whereas adjacent smaller and
bipolar cells were not stained. Micrographs were obtained using bright-
ﬁeld optics. Scale bars, 20 mm.
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wondered whether these might contribute to the long deactivation
tails. We tested this pharmacologically, using the HERG channel-
blocking drug WAY 123,398 (Spinelli et al., 1993; Faravelli et al.,
1996). As shown in Figure 1A,1 0mM WAY 123,398 blocked most
of the long deactivation, leaving a residual fast component which
was then eliminated by the M channel-blocking drug linopirdine
(Aiken et al., 1995; Lamas et al., 1997). In contrast, the fast-
deactivating current in Figure 1B was strongly blocked by linopir-
dine, leaving a slower component that was blocked in turn by
WAY 123,398. Thus, comparison of the linopirdine- and WAY-
sensitive currents (Fig. 1, inserts) showed that in fact each cell had
two components to the deactivation currents, fast and slow, and
that the overall time course of current deactivation was deter-
mined by their proportion. Furthermore, both components con-
tributed to the sustained current recorded at 220 mV.
Because 10 mM WAY 123,398 produces a complete block of erg
channels without affecting other K
1 channels such as sympathetic
neuron M channels (see below), we analyzed the fast and slow
components of the deactivation tails in more detail by recording
currents in the absence and presence of WAY 123,398. Figure 2
exempliﬁes the results obtained in 86 of 101 cells so examined.
Here, the control current recorded in the absence of WAY
123,398 (Fig. 2A) showed three components, a fast component
with a time constant of 76 msec, and a slower, biexponential
component with time constants of 340 msec and 2.1 sec. WAY
123,398 (Fig. 2B) eliminated the slower component, leaving only
the fast component (t, 75 msec), whereas the difference (WAY-
sensitive) current (Fig. 2C) showed only the biexponential slow
component (t, 315 msec and 2.0 sec). Thus, the time constants of
the residual current recorded after application of WAY 123,398
and of the subtracted (WAY-sensitive) current accurately repro-
Figure 5. Characteristics of the merg1a current
(Imerg1a) expressed in CHO cells. Imerg1a was acti-
vated by long (8 sec) depolarizing voltage steps
from the holding level of 280 mV (Aa) and deac-
tivated by hyperpolarizing steps after its full acti-
vation by a prepulse to 150 mV (Ba). Leak-
subtracted steady-state I–V relationships obtained
at the end of the depolarizing and hyperpolarizing
pulses, respectively, are shown in Ab and Bb (open
circles), and an “instantaneous” I–V relationship
obtained at the beginning of the hyperpolarizing
pulses for current deactivation is shown in Bb
( ﬁlled circles). Activation (Ac) and deactivation
(Bc) time constants were plotted semilogarithmi-
cally, and t–V relationships were ﬁtted by straight
lines with t at 0 mV and the slope equal to 1218 6
1 msec and 20.013 6 0.001 mV
21 in Ac and 403 6
1 msec and 0.012 6 0.0006 mV
21 ( ﬁlled circles) and
3437 6 1 msec and 0.014 6 0.002 mV
21 (open
circles)i nBc. C, Activation curve ﬁtted by the
Boltzmann equation at V1/2 52 5.9 6 0.6 mV and
k 5 12.2 6 0.5 mV. Records in Aa and Ba were
from the same cell. In Ab, Ac, Bb, Bc, and C the
mean data are shown (vertical lines indicate SEMs)
obtained from six and nine cells, respectively.
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current. In this cell, the fast and slow components contributed 70
and 30%, respectively of the total tail current, and both contrib-
uted to the steady outward current at the holding potential as
judged from the effect of WAY 123,398 on the holding current.
On average, in the 86 cells expressing both currents, the fast- and
slow-deactivating components contributed ;33 and 67%, respec-
tively, to the total tail current (Table 1). In the other 15 cells, the
tail current showed only the slowly deactivating component and
was fully suppressed by WAY 123,398.
mRNAs for merg1 and KCNQ2 and KCNQ3 in
NG108–15 cells
The clearly distinguishable effects of linopirdine and WAY
123,398 on the tail currents illustrated in Figures 1 and 2 sug-
gested that these might be composite currents, resulting from the
deactivation of two different species of K
1 channel: one com-
posed of linopirdine-sensitive KCNQ2/3 subunits, or homologs
thereof (Wang et al., 1998), and the other comprising a member
(or members) of the erg family. We therefore sought evidence for
the presence of transcripts of these channels by RT-PCR (see
Materials and Methods). Transcripts for both erg and KCNQ2/3
were detected (Fig. 3).
Sequence analysis of 10 independent clones from the erg PCR
showed that each clone contained erg1 DNA sequence (data not
shown), suggesting that these cells express predominantly, if not
exclusively, merg1 transcript (London et al., 1997). The KCNQ2/3
transcript contained mRNA for both KCNQ2 and KCNQ3.I tm a y
be noted in Fig. 3 that these transcripts were also present in
Figure 6. Comparison of the slow M-like
(IK(M,ng)) current in NG108–15 mouse neuro-
blastoma x rat glioma cells (A) and mouse-erg1a
current (Imerg1a) expressed in CHO cells (B).
The slowly deactivating component of IK(M,ng)
(Aa) was recorded in response to long hyperpo-
larizing steps (holding level, 220 mV; step du-
ration, 6 sec; interval, 60 sec; increment, 210
mV). These slow IK(M,ng) currents were obtained
by subtracting the currents recorded in the pres-
e n c eo f1 0mM WAY 123,398 (box, right) from
those in the absence of the blocker (box, left).
For comparison (Ba), Imerg1a is shown, obtained
with a similar voltage protocol (note the holding
potential of 0 mV in Ba). Deactivation tails were
ﬁtted by double-exponential curves (smooth
lines, superimposed). Leak-subtracted steady-
state ( ﬁlled circles) and instantaneous (open cir-
cles) I–V relationships for IK(M,ng) (Ab) and
Imerg1a (Ba) were obtained by measuring the
current at the beginning and end of the voltage
pulse. Fast ( ﬁlled circles) and slow (open circles)
time constants for deactivation of IK(M,ng) (Ac)
and Imerg1a (Bc) were plotted semilogarithmi-
cally against membrane potential, and t–V rela-
tionships were ﬁtted by straight lines with t at 0
mV and the slope equal to 2134 6 1 msec and
0.015 6 0.0009 mV
21 ( ﬁlled circles) and
15737 6 1 msec and 0.016 6 0.002 mV
21 (open
circles)i nAc and 680 6 1 msec and 0.011 6
0.0008 mV
21 ( ﬁlled circles) and 5432 6 1 msec
and 0.012 6 0.0007 mV
21 (open circles)i nBc.I n
Ab, Ac, Bb, and Bc the mean data are shown
(vertical lines indicate SEMs) obtained from 26
and 29 cells, respectively.
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1997; Wang et al., 1998).
Merg1 protein expression in chemically differentiated
NG108–15 cells
The presence of mRNA transcripts does not necessarily correlate
with translated protein products. We therefore tested for the
expression of merg1a protein in NG108 cells by immunocyto-
chemistry using a speciﬁc antibody raised against the C-terminal
fragment of merg1 (merg1-CT; see Materials and Methods). As a
control for speciﬁcity, the merg1-CT primary antibody was pre-
incubated overnight with a 10-fold molar excess of the immuno-
genic peptide. Figure 4, A and B, compare merg1 immunolabeling
in chemically differentiated and nondifferentiated NG108–15
cells, respectively. Strong labeling was observed in both cell
bodies and neuropil of most large chemically differentiated
NG108–15 cells of the type we normally selected for electrophys-
iological recording, whereas smaller cells with less well-developed
processes showed weak or no immunoreactivity. No staining was
observed in cells treated with preabsorbed antibody. Nondiffer-
entiated cells, which normally expressed very small IK(M,ng),
showed moderate or no staining. Interestingly, no staining was
observed in dissociated mouse SCG neurons (Fig. 4C), or over the
underlying glial cell layer. This latter (negative) ﬁnding accords
with the absence of any effect of WAY 123,398 on membrane
currents recorded from these neurons (see below). Also, no
immunostaining of differentiated NG108–15 cells was detected
after exposure to an antibody raised against an N-terminal se-
quence unique to the short form of merg1 (merg1b), the expres-
sion of which is restricted to cardiac cells (London et al., 1997).
This suggests that the protein tagged by the C-terminal antibody
is the product of the long-form transcript merg1a (London et al.,
1997; see also below).
Strong immunoreactivity for merg1-CT antibody was also de-
tected in CHO cells transfected with merg1a cDNA. No staining
was observed in untransfected cells, in cells transfected only with
the GFP plasmid, or in cells treated with preabsorbed antibody
(data not shown).
Slow IK(M,ng) is mimicked by merg1a current (Imerg1a)
expressed in CHO cells
The above results suggested that the slow component of the
M-like current in NG108–15 cells might well be carried by
merg1a channels. We tested this further by expressing merg1a
cDNA in mammalian CHO cells. Figure 5 illustrates the resultant
membrane currents. Imerg1a was activated by membrane depolar-
ization to equal or positive to 240 mV, but showed substantial
inactivation during the (long) depolarizing command at poten-
tials positive to 0 mV (Fig. 5Aa). As a result, the “steady-state”
current–voltage curve was “bell-shaped” (Fig. 5Ab). The time
course of this composite activation (accompanied by inactivation)
could be described by two exponentials, accelerating strongly
with depolarization (Fig. 5Ac). When the cell was hyperpolarized
after a depolarizing prepulse to 150 mV, there was a large
transient enhancement of the current, caused by removal of
channel inactivation, followed by a slower deactivation (Fig.
5Ba,b). Two deactivation components were detected that were
strongly shortened by membrane hyperpolarization (Fig. 5Bc).
The mean activation curve deduced from tail currents followed a
Boltzmann equation with V1/2 52 5.9 6 0.6 mV and k 5 12.2 6
0.5 mV (Fig. 5C). However, when individual curves were ﬁtted,
they showed a great variation in V1/2 (range, between 227 and 13
mV; n 5 9) and small variation in k (range, between 6.9 and 10).
These results accord well with previous observations on merg1a
currents in oocytes (London et al., 1997).
We next compared the properties of Imerg1a deactivation more
closely with those of the WAY-sensitive slow component of IK-
(M,ng), using the “standard” M current protocol, that is, currents
were preactivated by holding at the depolarized potential of 0 mV
(220 mV in the case of IK(M,ng), to avoid contamination by other,
primarily Ca
21-dependent, K
1 currents) and then deactivated by
6 sec step commands to various negative potentials. As shown in
Figure 6, there was a close correspondence between the two.
There were three main differences. First, deactivation of Imerg1a
was preceded by a larger transient reactivation: this presumably
reﬂected the greater steady-state inactivation of Imerg1a a t0m V
than that of slow IK(M,ng) at 220 mV. Second, the threshold for
activation of Imerg1a was ;10 mV more positive than that for slow
IK(M,ng) (Fig. 6Ab,Bb): the reason for this is not known but may
simply relate to different cell types. Third, whereas both showed
a biexponential deactivation, the time constants for the two
components of Imerg1a deactivation measured at 250 mV were
;40% of those for deactivation of the slow IK(M,ng) measured at
the same potential (Table 1). The time constants showed a com-
parable voltage dependence (Fig. 6,compare Ac, Bc), so this
Figure 7. The slow component of the NG108–15 M-like current and the
merg1a current are equally sensitive to WAY 123,398. Records in A and
B show the slow component of IK(M,ng) and Imerg1a deactivation tail
currents recorded on stepping from 0 to 250 mV in the presence of
increasing concentrations of WAY 123,398 (0, 0.3, 1, and 10 mM). Plots in
C show mean percent inhibition of the tail currents (open circles, IK(M,ng);
n 5 4; ﬁlled circles, Imerg1a; n 5 6). See Table 2 for ﬁtted parameters.
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and/or the different size of the voltage step (in four CHO cells
using a prepulse protocol, the ﬁrst and the second slow deactiva-
tion t values for Imerg1a were slower after a prepulse to 220 mV
compared with a prepulse to 0 mV, by 41 and 57%, respectively).
For comparison, we also examined the properties of currents
generated by the short “cardiac” isoform merg1b expressed in
CHO cells (Imerg1b; n 5 3; data not shown). Whereas the voltage
dependence of Imerg1b activation and deactivation were very sim-
ilar to that of the slow IK(M,ng) and of Imerg1a, both activation and
deactivation of Imerg1b were several times faster (Table 1), as
previously reported in oocytes by London et al. (1997) (see also
Lees-Miller et al., 1997). Hence, and in accordance with the lack
of antibody staining mentioned above and the absence of merg1b
mRNA expression in the nervous system (London et al., 1997), it
is unlikely that merg1b channels contribute to slow IK(M,ng).
Slow IK(M,ng) and Imerg1a show similar pharmacology
We next compared the sensitivity of the slowly deactivating
component of the NG108–15 current IK(M,ng) with that of CHO-
expressed merg1a currents to some blocking drugs. As shown in
Figure 7, both tail currents were blocked by the anti-arrhythmic
drug WAY 123,398 with equal facility (IC50 values, 0.4 and 0.3 mM,
respectively; Table 2). They were also equally sensitive to another
anti-arrhythmic drug, azimilide (IC50 values, 6.4 and 6.5 mM,
respectively; Table 2; Busch et al., 1998). Imerg1a was also inhibited
by 9-aminotetrahydroacridine (THA;IC50 value, 36 mM; Table 2),
a compound that had previously proved unexpectedly potent in
inhibiting the M-like current in NG108–15 cells (Robbins et al.,
1992). In contrast, neither current was inhibited by the ganglionic
M channel- and KCNQ2/3 channel-blocking agent linopirdine at
concentrations up to 30 mM [Noda et al. (1998) reported an IC50
of 36 mM against the NG108–15 current, but this was measured
from the depression of the composite current, and the Hill slope
was rather shallow, so probably reﬂected its primary action on the
fast current component, see below]. Also, both currents were very
insensitive to tetraethylammonium (TEA), with IC50 values of 17
and 24 mM (Table 2). Thus, Imerg1a provides a good match for the
slowly deactivating component of IK(M,ng), both kinetically and
pharmacologically.
Fast IK(M,ng) is mimicked by the M current (IK(M))i n
mouse sympathetic neurons
As noted above (Fig. 1), the fast component of IK(M,ng) was
readily suppressed by 10 mM linopirdine. Since linopirdine blocks
M currents in sympathetic ganglia (Lamas et al., 1997; Wang et
al., 1998), this suggested that fast IK(M,ng) might correspond to the
“true” (ganglionic-type) M current. We assessed this by compar-
ing fast WAY-insensitive IK(M,ng) with the M current recorded
from dissociated mouse SCG neurons. (We used mouse neurons
because (1) the parent neuroblastoma to the NG108–15 hybrid
cell line is derived from mouse neural crest; and (2) sequence
analysis of the PCR products obtained with the KCNQ primers
showed that NG108–15 cells expressed both the mouse KCNQ2
and the mouse KCNQ3. Because we have successfully used these
primers to amplify the rat KCNQ2 and KCNQ3 genes, we con-
clude that NG108–15 cells express predominantly, if not exclu-
sively, the mouse KCNQ genes.) Figure 8 shows families of fast
IK(M,ng) (Aa) and IK(M) (Ba) activated by membrane depolariza-
Table 2. Effects of K
1 channel blockers on fast and slow IK(M,ng), Imerg1a, and IK(M)
Blocker Slow IK(M,ng) Imerg1a Fast IK(M,ng) IK(M)
WAY 123,398
IC50 (mM) 0.4 6 0.07 0.3 6 0.02 no effect (10 mM) no effect (10 mM)
nH 1.0 6 0.2 0.9 6 0.07
(4) (6) (37) (9)
Azimilide
IC50 (mM) 6.5 6 0.7 6.4 6 0.3 31.1 6 1.8 12.9 6 0.7
nH 0.9 6 0.08 0.8 6 0.03 0.9 6 0.05 1.3 6 0.09
(5) (4) (4) (3)
THA
IC50 (mM) 11.5 6 1.5 35.7 6 9.7 1542 6 200 1279 6 75
nH 0.6 6 0.05 0.6 6 0.1 0.7 6 0.07 0.8 6 0.03
(3) (7) (3) (4)
Linopirdine
IC50 (mM) ..30 .30 1.2 6 0.02 3.5 6 0.2
nH 1.2 6 0.03 0.8 6 0.04
(4) (6) (6) (6)
TEA
IC50 (mM) 16.7 6 3.4 24.1 6 3.6 1.1 6 0.09 10.9 6 0.7
nH 0.8 6 0.1 0.6 6 0.1 0.6 6 0.03 0.6 6 0.02
(6) (3) (5) (4)
Ba
21
IC50 (mM) 134 6 6 492 6 57 248 6 26 393 6 36
nH 1.0 6 0.04 1.0 6 0.1 0.9 6 0.07 0.8 6 0.05
(3) (5) (3) (3)
Mean 6 SEM. Number of cells in parentheses. Inhibition constants (IC50) were determined from dose–response curves of
the type illustrated in Figures 7 and 9. Effects on fast and slow currents in NG108-15 cells were determined from kinetic
analysis of deactivation tails as illustrated in Figure 2, supplemented (where appropriate) by tests after inhibiting the slow
component with WAY 123,398, as in Figure 9.
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230 to 2100 mV. The slow component of IK(M,ng) was eliminated
using 10 mM WAY 123,398, as shown in the box in Figure 8. Fast
IK(M,ng) and IK(M) had similar voltage dependences (Fig. 8A,B)t o
each other, and also to slow IK(M,ng) and Imerg1a (compare Fig. 6).
However, unlike slow IK(M,ng), deactivation tails of fast IK(M,ng)
and mouse IK(M) were ﬁtted with single exponential curves: these
had time constants similar to each other but much shorter than
those in the slow IK(M,ng) and Imerg1a (Table 1).
Pharmacological comparison of fast IK(M,ng) and
mouse IK(M)
Like fast IK(M,ng), mouse IK(M) was unaffected by 10 mM WAY
123,398. IK(M) recorded from 5 rat SCG neurons was also insen-
sitive to this compound. Furthermore, both fast IK(M,ng) and
mouse IK(M) were 1.5–2 orders of magnitude less sensitive to
THA than were slow IK(M,ng) or Imerg1a (IC50 values, 1.5 and 1.3
mM; Table 2). This accords with the relative insensitivity of rat
SCG IK(M) to THA reported previously (Marsh et al., 1990).
Figure 9 shows the responses of fast IK(M,ng) and mouse IK(M) to
linopirdine and TEA. Whereas both currents were considerably
more sensitive than slow IK(M,ng) or Imerg1a to linopirdine, the
neuroblastoma–glioma current was clearly more sensitive than
the mouse SCG current (IC50 values, 1.2 and 3.5 mM, respectively;
Table 2). Likewise, fast IK(M,ng) was more readily blocked than
the mouse IK(M) by TEA (see Discussion). Nevertheless, although
not completely identical pharmacologically, fast IK(M,ng) and
Figure 8. Characteristics of the fast M-like
(IK(M,ng)) current in a NG108–15 mouse neuro-
blastoma x rat glioma cell (A) and the M cur-
rent (IK(M)) in a mouse SCG neuron (B). The
fast-deactivating component of IK(M,ng) (Aa)
was recorded in the presence of 10 mM WAY
123,398 at different membrane potentials (hold-
ing level, 220 mV; step duration, 1 sec; interval,
10 sec; increment, 210 mV). Box, Inhibition of
the slow, WAY-sensitive component in this cell:
currents before and after application of 10 mM
WAY 123,398, left, and the difference current,
right. For comparison (Ba), IK(M) is shown, ob-
tained with the same voltage protocol. Deacti-
vation tails were ﬁtted by single exponential
curves (smooth lines, superimposed). Leak-
subtracted steady-state ( ﬁlled circles) and in-
stantaneous (open circles) I–V relationships for
IK(M,ng) (Ab) and IK(M) (Ba) were obtained by
measuring the current at the beginning and end
of the voltage pulse. When the time constants
for deactivation of IK(M,ng) (Ac) and IK(M) (Bc)
were plotted semilogarithmically against mem-
brane potential, t–V relationships were ﬁtted by
straight lines with t at 0 mV and the slope equal
to 271 6 1 msec and 0.009 6 0.0004 mV
21 in Ac
and 399 6 1 msec and 0.013 6 0.0009 mV
21 in
Bc.I nAb, Ac, Bb, and Bc the mean data are
shown (vertical lines indicate SEM) obtained
from 30 and 15 cells, respectively.
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ous difference from slow IK(M,ng) and Imerg1a.
Both fast and slow IK(M,ng), and Imerg1a, are inhibited
through activation of M1 muscarinic receptors
Activation of M1 muscarinic receptors inhibits both the total
(composite) M-like current (IK(M,ng)) in NG108–15 cells (Fukuda
et al., 1988; Robbins et al., 1991, 1993), and the M current IK(M)
in rat (Marrion et al., 1989; Bernheim et al., 1992) and mouse
(Hamilton et al., 1997) sympathetic neurons. We therefore exam-
ined the effects of a muscarinic stimulant, oxotremorine-M
(Oxo-M; 10 mM), on each component of IK(M,ng),a sw e l la sImerg1a,
in M1 muscarinic receptor-transformed NG108–15 and CHO
cells. Figure 10 shows that Oxo-M inhibited the slow IK(M,ng) (A)
and Imerg1a (B). Such inhibitions were observed in seven of eight
NG108–15 cells (mean inhibition, 42.3 6 13.8%) and six of six
merg1a-expressing CHO cells (mean inhibition, 50.7 6 10.8%).
Inhibition of both slow IK(M,ng) and Imerg1a was accompanied by a
signiﬁcant acceleration of their deactivation kinetics (Fig. 11): on
average, the two components in slow IK(M,ng) and Imerg1a were
shortened by 25.4 6 10.0% and 34.6 6 9.0% (n 5 6) and 36.5 6
4.8% and 27.8 6 10.1% (n 5 4), respectively.
Figure 12 shows examples of inhibitions of fast IK(M,ng) and
mouse IK(M) by Oxo-M. Such inhibitions were observed in four of
four NG108–15 cells (mean inhibition, 72.6 6 13.8%; n 5 4). As
expected (Hamilton et al., 1997), similar inhibition was consis-
tently observed in sympathetic neurons.
Fast and slow IK(M,ng) control ﬁring in NG108–15 cells
The function of the M current is to act as a brake on repetitive
ﬁring. Thus, inhibition of the M current in sympathetic neurons,
either by muscarinic agonists (Brown and Selyanko, 1985) or by
an M channel-blocking agent (Wang et al., 1998), is associated
with increased repetitive ﬁring during depolarizing current injec-
tions. A similar effect has also been reported in M1-transformed
NG108–15 cells after application of a muscarinic agonist (Rob-
bins et al., 1993). However, in the latter case, it is not clear
whether this results from inhibition of the fast or slow IK(M,ng),o r
both. We tested this by injecting long (7 sec) depolarizing cur-
rents into NG108–15 cells and then observing the effects of
Figure 9. Differential sensitivities of fast IK(M,ng) and
IK(M) to linopirdine and TEA. The fast (WAY-insensitive)
component of IK(M,ng) and IK(M) was recorded in response
to 1 sec steps from the holding level of 220 to 250 mV, in
the absence and presence of different concentrations of
linopirdine (Aa, Ab) and TEA (Ba, Bb). C, Concentration
dependences of inhibition of the two currents by linopir-
dine (a) and TEA (b). Smooth lines are the ﬁts by the Hill
equation. For the parameters of the ﬁt see Table 2.
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WAY 123,398, respectively. The depolarizing currents produced
a short burst of repetitive ﬁring in 20 of 22 NG108–15 cells tested
and single action potentials in the remaining two cells. Figure 13
shows that 30 mM linopirdine (which blocked the fast current
completely and inhibited the slow IK(M,ng) by only 33%) produced
a strong reduction in spike adaptation, whereas 10 mM WAY
123,398 had a much weaker effect. Neither linopirdine nor WAY
123,398 had any effect on spike repolarization.
DISCUSSION
The main point emerging from this work is that the M-like
current in NG108–15 cells (IK(M,ng)) is a composite current gen-
erated by at least two channel types: a fast-deactivating set of
channels similar (but not quite identical) to those carrying the M
current in mouse sympathetic neurons and tentatively identiﬁed
as KCNQ2/KCNQ3 (Wang et al., 1998), and a slower-deactivating
current probably formed from merg1a (London et al., 1997).
KCNQ2 and KCNQ3 are analogs of KCNQ1, which coassembles
with KCNE (minK) subunits to give the cardiac current IKs (the
slow component of the cardiac “delayed rectiﬁer”), and mutation
of which causes one form of the cardiac long QT syndrome (Yang
et al., 1997). KCNQ2 and KCNQ3 have so far been detected only
in brain and ganglia, and are implicated in a form of juvenile
epilepsy (Biervert et al., 1998; Charlier et al., 1998; Schroeder et
al., 1998; Singh et al., 1998; Yang et al., 1998). Merg1a is one
isoform of the mouse homolog of erg, originally cloned from a rat
brain hippocampal cDNA library (Warmke and Ganetzky, 1994);
mRNA for erg is found mainly in heart and brain (London et al.,
1997; Wymore et al., 1997). Mutations of the human homolog
HERG give rise to a cardiac long QT syndrome (Curran et al.,
1995; Sanguinetti et al., 1996), whereas mutations in Drosophila
erg are responsible for the seizure phenotype associated with
hyperactivity in the ﬂight motor pathway (Titus et al., 1997; Wang
et al., 1997). Thus, both these channel types have been implicated
Figure 10. Muscarinic inhibition of slow IK(M,ng) in a
NG108–15 mouse neuroblastoma x rat glioma cell (A) and
Imerg1a expressed in a CHO cell (B). Currents (Aa, Ba) were
produced by holding at 220 mV (A)o r0m V(B) and giving
repeated steps (at 0.02 Hz in A and 0.025 Hz in B)t o250 mV
for 6 sec. Both steady-state currents at the holding potentials
and deactivation currents at the test potential were reduced
by bath-application of oxotremorine-M (Oxo-M;1 0mM). In
an NG108–15 cell, inhibition of IK(M,ng) was preceded by a
transient activation of a Ca
21-activated K
1 current (Aa).
Families of currents in b and c were obtained in response to
incremental (210 mV) hyperpolarizing voltage steps before
(b) and during (c) action of Oxo-M. The insert in B shows
superimposed current produced by voltage steps from 0 to
250 mV before and during the action of Oxo-M.
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these two channels forming overlapping and functionally similar
components of membrane current.
Our conclusion that two different channels are involved is
based on: (1) the presence of mRNA transcripts and protein; (2)
biophysical properties (voltage threshold and deactivation param-
eters); (3) sensitivity to potassium channel blockers; and (4)
modulation of the channel by an agonist. Thus, we demonstrate
the presence of mRNA and protein for merg1, and mRNA for
KCNQ2 and KCNQ3, in NG108–15 cells. We show that the
kinetics of merg1a heterologously expressed in mammalian cells
correspond closely to those of the slow IK(M,ng). We also show that
the two are equally sensitive to the merg-selective blocking agents
WAY 123,398 and azimilide, and insensitive to the ganglionic M
current and KCNQ2/3 channel-blocking agent linopirdine. On the
other hand, we ﬁnd that the fast IK(M,ng) kinetically matches the
mouse SCG IK(M), that these two are pharmacologically similar
(although not quite identical), and that they can be distinguished
from both slow IK(M,ng) and Imerg1a by their greater sensitivity to
linopirdine and insensitivity to WAY 123,398. We also show that
both fast and slow components of IK(M,ng) are inhibited by stim-
ulating M1 muscarinic acetylcholine receptors and that the nature
of the inhibition of these two components matches that for inhi-
bition of mouse IK(M) and Imerg1a, respectively.
IK(M) in rat ganglion cells has been ascribed to current through
channels composed of heteromultimeric assemblies of expressed
KCNQ2 and KCNQ3 subunits (Wang et al., 1998). This may also
be true for IK(M) in mouse ganglion cells and for the fast compo-
nent of IK(M,ng) in NG108–15 cells, because we have found that
both cell types show transcripts for these subunits. However, as
yet, we cannot exclude a contribution from other, homologous,
KCNQ subunits. Furthermore, fast IK(M,ng) was distinctly more
sensitive to TEA and to linopirdine than was mouse ganglion
IK(M), suggesting that the subunit composition of the presumed-
KCNQ channels in these two cell types might differ.
The presence of functional merg1a channels in these cells is
not, in itself, particularly surprising, because mRNA transcripts
have been identiﬁed in a number of neuroblastoma-derived cells
Figure 11. Muscarinic inhibition of slow IK(M,ng) in a NG108–15 mouse
neuroblastoma x rat glioma cell (A) and Imerg1a expressed in a CHO cell
(B) is accompanied by acceleration of their deactivation kinetics. Super-
imposed are deactivation tails obtained by stepping to 250 mV from 220
mV (A)o r0m V( B) in control (Con) and in the presence of 10 mM
oxotremorine-M (Oxo). Smooth lines are double-exponential ﬁts with time
constants (indicated by arrows) equal to 276 and 1271 msec (Con) and 176
and 708 msec (Oxo)i nA and 92 and 398 msec (Con) and 71 and 290 msec
(Oxo)i nB.
Figure 12. Muscarinic inhibition of fast IK(M,ng) in an NG108–15 mouse
neuroblastoma x rat glioma cell (A) and IK(M) in a mouse sympathetic
neuron (B). Fast-deactivating IK(M,ng) currents (A) are shown during 1 sec
of hyperpolarization from 220 to 250 mV, before and during the action
of oxotremorine-M (Oxo-M;1 0mM). Both currents were obtained in the
presence of 10 mM WAY 123,398. (The effect of WAY 123,398 on the total
IK(M,ng) recorded in this cell with a longer, 6 sec pulse, is shown in the
box.) Currents in a mouse sympathetic neuron were obtained before and
after addition of WAY 123,398 and WAY 123,398 1 Oxo-M.
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HERG (Bianchi et al., 1998), and an “inwardly rectifying” cur-
rent, retrospectively similar to an erg current, was reported in
NG108–15 cells by Hu and Shi (1997) (see also Bianchi et al.,
1998). However, in previous experiments, the properties of this
current were mostly studied using solutions containing a raised
K
1 concentration, so that its relation to the M-like current was
difﬁcult to discern. It is clear from the present experiments (using
normal external K
1 concentrations) that the activation range of
Imerg1a overlaps that of the true IK(M), but that deactivation of
Imerg1a contributes a distinctive slow component to composite
current deactivation; and furthermore, that the proportional con-
tributions of Imerg1a and IK(M) to the total M-like current vary
appreciably from cell to cell.
The merg1a and (presumed) KCNQ currents also overlap func-
tionally. Thus, Chiesa et al. (1997) have provided evidence that
erg channels play a role in spike frequency adaptation in another
neuroblastoma-derived cell line, not dissimilar to the role of
ganglionic M channels (Jones and Adams, 1987; Brown, 1988). In
the present experiments, it appeared that inhibition of the fast
(M) channels had more effect on the response of NG108–15 cells
to a sustained current injection than did inhibition of the slow
(merg) channels (Fig. 13). However, the relative contribution of
these two currents to spike frequency adaptation may depend on
the nature of the testing pulse protocol, because merg currents
activate and deactivate more slowly than KCNQ currents, and
hence accumulate during repetitive depolarization (Schonherr et
al., 1999).
The transduction mechanism for M1-mediated inhibition of
KCNQ2/3 and merg1 is still unknown. Inhibition of Imerg1a and
slow IK(M,ng) was accompanied by accelerated deactivation, which
may indicate the involvement of protein kinase C (PKC); in
HERG currents expressed in Xenopus oocytes, similar accelera-
tion produced by thyrotropin-releasing hormone receptor activa-
Figure 13. Effects of inhibiting fast and slow IK(M,ng) on
ﬁring in NG108–15 cells. Records show action potential
trains in two NG108–15 cells (A, B) produced by long (7
sec) depolarizing pulses (top records) from the holding
potential of 290 mV in the absence of drugs (Aa, Ba), in
the presence of 30 mM linopirdine (Ab), 10 mM WAY
123,398 (Bb), or in the presence of both linopirdine and
WAY 123,398 (Ac, Bc).
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accord with an earlier proposal regarding the mechanism of
inhibition of the M-like current in NG108–15 cells by bradykinin
(Higashida and Brown, 1986). Although M1 receptor activation in
NG108–15 cells produces a strong elevation in intracellular
[Ca
21] (Robbins et al., 1993), it is unlikely that Ca
21 could be a
messenger for muscarinic inhibition of slow IK(M,ng) or Imerg1a
because, in CHO cells, the Ca
21 ionophore ionomycin (5 mM)
produced an insigniﬁcant reduction in Imerg1a (to 89.4 6 9.7% of
control; n 5 3). As a control for the effectiveness of ionomycin in
these cells, it caused a complete block of Kv1.2 channels ex-
pressed in CHO cells when recorded in perforated-patch or
cell-attached conﬁgurations; direct application of 500 nM Ca
21
blocked Kv1.2 channels when recorded in the inside-out conﬁg-
uration (A. A. Selyanko and J. K. Hadley, unpublished
observations).
Do products of erg genes contribute to M-like currents in other
neurons? Transcripts for merg1 (London et al., 1997), and for the
rat homologs erg1 and erg3 (Shi et al., 1997; Wymore et al., 1997)
are present in mammalian brain. Furthermore, both expressed
merg1a currents and the slow, presumed-merg1a component of
the M-like current in NG108–15 cells were inhibited by stimulat-
ing M1 muscarinic receptors, so they could contribute to
muscarinic-inhibitable M-like currents previously recorded in
central neurons. True, the presence of mRNA transcripts may not
betoken the assembly of functional channels: thus, no appropriate
erg-like component of membrane current could be recorded from
mouse or rat sympathetic neurons, in spite of the presence of
mRNAs (Shi et al., 1997; see also this paper), nor could we detect
merg1 immunoreactivity. However, this may not be the case for
other mammalian neurons. For example, the M-like current re-
corded from isolated rat cortical neurons has been reported to be
an order of magnitude less sensitive to linopirdine than either the
ganglionic or hippocampal cell current (Noda et al., 1998; cf.
Aiken et al., 1995; Lamas et al., 1997; Schnee and Brown, 1998).
Although other explanations are possible, our ﬁndings suggest
that this might arise from a contribution by erg channels to the
cortical neuron current. In view of the signiﬁcance of M-like
channels as potential targets for cognition-enhancing drugs (Zac-
zek and Saydoff, 1993), further information regarding the degree
of heterogeneity in the molecular composition of the channels
underlying M-like currents in different neurons would be helpful.
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